Multiple Myeloma: An Overview

Brent Devenney

Christy Erickson

multiple myeloma, thalidomide, antineoplastic agents
CJON 2004, 8(4), 401-405. DOI: 10.1188/04.CJON.401-405

Multiple myeloma (MM) is a malignant hematologic disorder involving plasma cells. In MM, immunoglobulin is overproduced, and patients can develop skeletal, hematologic, renal, and/or neurologic complications. The exact etiology of MM is unknown. The treatment for MM includes chemotherapy, antiangiogenic medications, and, most recently, a proteasome inhibitor. Nursing care for patients with MM requires close monitoring for infections and anemia, pain control, and education about the disease and treatment options. Further understanding of the pathophysiology of MM may lead to newer treatment options for the disease.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.